
  
    
      
        Background_NNP
        Reduction_NNP in_IN hypothalamic_JJ melanocortin_NN tone_NN ,_, caused_VBN by_IN
        reduction_NN in_IN proopiomelanocortin_NN (_( POMC_NNP )_) mRNA_NN and_CC elevation_NN
        in_IN agouti-related_JJ peptide_NN (_( AGRP_NNP )_) mRNA_NN ,_, is_VBZ thought_VBN to_TO play_VB a_DT
        key_JJ role_NN in_IN mediating_VBG nutritional_JJ effects_NNS on_IN neuroendocrine_NN
        function_NN [_NN 1_CD 2_CD ]_NN ._. Thus_RB fasting_VBG [_NN 3_CD 4_CD ]_NN ,_, insulin_NN
        deficiency_NN [_NN 5_CD ]_NN ,_, and_CC leptin_NN deficiency_NN [_NN 4_CD ]_NN are_VBP all_DT
        associated_VBN with_IN reduced_VBN hypothalamic_JJ melanocortin_NN tone_NN ._.
        However_RB ,_, factors_NNS that_WDT regulate_VB hypothalamic_JJ melanocortin_NN
        tone_NN are_VBP not_RB fully_RB elucidated_JJ ._. Since_IN both_DT fasting_VBG and_CC
        insulin_NN deficiency_NN are_VBP associated_VBN with_IN reduced_VBN plasma_NN
        leptin_NN [_NN 5_CD ]_NN ,_, and_CC leptin_NN replacement_NN reverses_VBZ effects_NNS of_IN
        fasting_VBG [_NN 6_CD ]_NN and_CC also_RB effects_VBZ of_IN insulin_NN deficiency_NN on_IN
        food_NN intake_NN and_CC body_NN weight_NN [_NN 7_CD ]_NN ,_, it_PRP has_VBZ been_VBN suggested_VBN
        that_IN the_DT reduction_NN in_IN leptin_NN accounts_NNS for_IN the_DT reduced_VBN
        hypothalamic_JJ melanocortin_NN tone_NN in_IN these_DT conditions_NNS ._.
        However_RB ,_, fasting_VBG can_MD influence_VB hypothalamic_JJ gene_NN expression_NN
        in_IN insulin-deficient_JJ mice_NNS independent_JJ of_IN changes_NNS in_IN plasma_NN
        leptin_NN or_CC insulin_NN [_NN 5_CD ]_NN ,_, as_RB well_RB as_IN in_IN leptin_NN resistant_JJ 
        db_NN /_NN db_NN mice_NNS [_NN 3_CD ]_NN ._. These_DT data_NNS suggest_VBP
        that_IN other_JJ factors_NNS in_IN addition_NN to_TO leptin_NN may_MD mediate_VB
        effects_NNS of_IN fasting_VBG ._. Since_IN fasting_VBG ,_, insulin_NN deficiency_NN ,_, and_CC
        leptin_NN insufficiency_NN also_RB lead_VB to_TO an_DT elevation_NN in_IN plasma_NN
        glucocorticoids_NNS [_NN 8_CD ]_NN ,_, and_CC adrenalectomy_NN of_IN
        leptin-deficient_JJ 
        ob_NN /_NN ob_NN mice_NNS largely_RB normalizes_NNS
        hypothalamic_JJ gene_NN expression_NN in_IN these_DT mice_NNS [_NN 9_CD ]_NN ,_, it_PRP is_VBZ
        plausible_JJ that_WDT elevated_VBD glucocorticoids_NNS may_MD mediate_VB some_DT
        effects_NNS of_IN nutritional_JJ state_NN on_IN hypothalamic_JJ gene_NN
        expression_NN ._. This_DT hypothesis_NNS is_VBZ particularly_RB compelling_JJ
        since_IN recent_JJ data_NNS suggest_VBP that_DT aberrant_NN glucocorticoid_NN
        activity_NN may_MD play_VB a_DT key_JJ role_NN in_IN the_DT development_NN of_IN the_DT
        metabolic_JJ syndrome_NN [_NN 10_CD ]_NN ._.
        Glucocorticoids_NNP have_VBP previously_RB been_VBN reported_VBN to_TO
        increase_VB body_NN weight_NN set_VBD point_NN ,_, as_IN determined_VBN by_IN hoarding_VBG
        behavior_NN in_IN rats_NNS [_NN 11_CD ]_NN ,_, while_IN adrenalectomy_NN has_VBZ been_VBN
        reported_VBN to_TO lower_JJR body_NN weight_NN set_VBD point_NN in_IN rats_NNS [_NN 12_CD ]_NN ._. In_IN
        addition_NN ,_, central_JJ infusion_NN of_IN glucocorticoids_NNS leads_VBZ to_TO
        increases_NNS in_IN body_NN weight_NN and_CC food_NN intake_NN with_IN a_DT concomitant_NN
        induction_NN of_IN hypothalamic_JJ NPY_NNP [_NN 13_CD ]_NN ._. Nevertheless_RB ,_, it_PRP
        remains_VBZ unclear_JJ if_IN an_DT elevation_NN in_IN glucocorticoid_NN
        concentration_NN contributes_VBZ to_TO the_DT effect_NN of_IN fasting_VBG on_IN
        hypothalamic_JJ gene_NN expression_NN ._. Adrenalectomy_NNP has_VBZ been_VBN
        reported_VBN to_TO block_VB elevations_NNS in_IN NPY_NNP mRNA_NN in_IN response_NN to_TO
        fasting_VBG [_NN 14_CD ]_NN ._. On_IN the_DT other_JJ hand_NN ,_, it_PRP has_VBZ been_VBN reported_VBN
        that_DT elevation_NN of_IN plasma_NN corticosterone_NN levels_NNS is_VBZ not_RB
        required_VBN for_IN the_DT induction_NN of_IN NPY_NNP mRNA_NN by_IN fasting_VBG [_NN 15_CD ]_NN ._.
        In_IN addition_NN ,_, the_DT extent_NN to_TO which_WDT hypothalamic_JJ AGRP_NNP and_CC POMC_NNP
        mRNA_NN depends_VBZ on_IN elevated_JJ glucocorticoid_NN levels_NNS in_IN fasting_VBG
        and_CC insulin_NN deficiency_NN has_VBZ not_RB been_VBN determined_VBN to_TO date_NN ._.
        Therefore_RB in_IN the_DT present_JJ study_NN we_PRP assessed_VBD if_IN an_DT elevation_NN
        of_IN plasma_NN corticosterone_NN is_VBZ necessary_JJ and_CC sufficient_JJ to_TO
        mediate_VB effects_NNS of_IN fasting_VBG and_CC insulin_NN deficiency_NN on_IN
        hypothalamic_JJ melanocortin_NN tone_NN ,_, as_IN indicated_VBN by_IN expression_NN
        of_IN hypothalamic_JJ AGRP_NNP and_CC POMC_NNP mRNA_NN ._.
      
      
        Results_NNS and_CC Discussion_NNP
        
          Study_NNP 1_CD :_: Effects_NNPS of_IN adrenalectomy_NN on_IN hypothalamic_JJ
          responses_NNS to_TO fasting_VBG
          Fasting_NNP reduced_VBD body_NN weight_NN and_CC adipose_NN weight_NN in_IN both_DT
          the_DT sham-operated_JJ and_CC adrenalectomized_JJ groups_NNS as_IN expected_VBN
          (_( Table_NNP 1_LS )_) ._. Blood_NNP glucose_NN was_VBD also_RB decreased_VBN by_IN fasting_VBG in_IN
          both_DT the_DT sham-operated_JJ group_NN and_CC adrenalectomized_JJ group_NN
          (_( Table_NNP 1_LS )_) ._. Serum_NNP corticosterone_NN concentration_NN increased_VBD
          with_IN fasting_VBG as_IN expected_VBN in_IN the_DT sham-operated_JJ mice_NNS (_( Fig_NNP ._.
          1_LS A_DT )_) ;_: adrenalectomy_NN blocked_VBD this_DT fasting-induced_JJ elevation_NN
          of_IN corticosterone_NN (_( Fig_NNP ._. 1_LS A_DT )_) ._. Therefore_RB the_DT
          adrenalectomized_JJ fasted_JJ mice_NNS exhibited_VBN similar_JJ levels_NNS of_IN
          corticosterone_NN as_IN both_DT the_DT adrenalectomized_JJ ad_NN lib_NN fed_VBD
          mice_NNS and_CC the_DT sham-operated_JJ ad_NN lib_NN fed_VBD mice_NNS (_( Fig_NNP ._. 1_LS A_DT )_) ._. As_IN
          we_PRP noted_VBD previously_RB ,_, a_DT basal_NN level_NN of_IN corticosterone_NN was_VBD
          detectable_JJ in_IN the_DT adrenalectomized_JJ mice_NNS after_IN surgery_NN [_NN 9_CD
          ]_NN ._. In_IN contrast_NN to_TO corticosterone_NN ,_, other_JJ humoral_NN factors_NNS
          were_VBD not_RB significantly_RB affected_VBN by_IN adrenalectomy_NN ._. Serum_NNP
          insulin_NN and_CC serum_NN leptin_NN both_DT exhibited_VBN the_DT same_JJ
          decreases_NNS in_IN the_DT adrenalectomized_JJ fasted_JJ and_CC
          sham-operated_JJ fasted_JJ animals_NNS compared_VBN to_TO the_DT
          adrenalectomized_JJ ad_NN lib_NN fed_VBN and_CC sham-operated_JJ ad_NN lib_NN fed_VBD
          mice_NNS (_( Fig_NNP ._. 1_LS Band_NNP 1_CD C_NNP )_) ;_: therefore_RB the_DT levels_NNS of_IN these_DT
          humoral_NN factors_NNS were_VBD the_DT same_JJ in_IN the_DT sham-operated_JJ fasted_JJ
          mice_NNS and_CC the_DT adrenalectomized_JJ fasted_JJ mice_NNS ._.
          Fasting_NNP increased_VBD hypothalamic_JJ AGRP_NNP mRNA_NN as_IN expected_VBN
          in_IN the_DT sham-operated_JJ fasted_JJ group_NN ,_, and_CC adrenalectomy_NN
          completely_RB blocked_VBD the_DT induction_NN of_IN AGRP_NNP by_IN fasting_VBG (_( Fig_NNP ._.
          2_LS A_DT )_) ._. Adrenalectomy_NNP also_RB produced_VBD a_DT trend_NN to_TO decrease_VB AGRP_NNP
          mRNA_NN in_IN the_DT ad-lib_JJ fed_VBN mice_NNS but_CC this_DT effect_NN was_VBD not_RB
          significant_JJ (_( Fig_NNP ._. 2_LS A_DT )_) ._. Fasting_NNP decreased_VBD hypothalamic_JJ
          POMC_NNP mRNA_NN as_IN expected_VBN in_IN the_DT sham-operated_JJ fasted_JJ group_NN ,_,
          but_CC fasting_VBG had_VBN no_DT effect_NN on_IN POMC_NNP mRNA_NN in_IN the_DT
          adrenalectomized_JJ animals_NNS (_( Fig_NNP ._. 2_LS B_NNP )_) ._. As_IN with_IN AGRP_NNP ,_, NPY_NNP
          mRNA_NN was_VBD also_RB elevated_VBD after_IN fasting_VBG ,_, and_CC this_DT effect_NN of_IN
          fasting_VBG on_IN NPY_NNP mRNA_NN was_VBD also_RB completely_RB blocked_VBN by_IN
          adrenalectomy_NN (_( Fig_NNP 2_CD C_NNP )_) ._. Adrenalectomy_NNP therefore_RB
          completely_RB blocked_VBD the_DT effects_NNS of_IN fasting_VBG on_IN hypothalamic_JJ
          AGRP_NNP ,_, POMC_NNP and_CC NPY_NNP mRNAs_NNS ._.
        
        
          Study_NNP 2_CD :_: Effects_NNPS of_IN adrenalectomy_NN on_IN hypothalamic_JJ
          responses_NNS to_TO insulin_NN deficiency_NN and_CC fasting_VBG
          Streptozotocin_NNP injection_NN induced_VBD diabetes_NN in_IN
          sham-operated_JJ mice_NNS (_( Table_NNP 2_LS )_) ._. Interestingly_RB ,_,
          adrenalectomy_NN attenuated_JJ the_DT rise_NN in_IN blood_NN glucose_NN in_IN
          streptozotocin-injected_JJ mice_NNS (_( Table_NNP 2_LS )_) ._. Fasting_NNP reduced_VBD
          blood_NN glucose_NN in_IN the_DT ADX-STZ-Fast_NNP group_NN below_IN even_RB that_IN
          of_IN control_NN mice_NNS (_( Table_NNP 2_LS )_) ._. Streptozotocin_NNP injection_NN led_VBN
          to_TO reduced_VBN body_NN weight_NN and_CC adiposity_NN in_IN sham-operated_JJ
          animals_NNS as_RB previously_RB described_VBD [_NN 5_CD 17_CD ]_NN (_( Table_NNP 2_LS )_) ,_,
          whereas_IN adrenalectomy_NN attenuated_JJ the_DT loss_NN of_IN both_DT body_NN
          weight_NN and_CC adiposity_NN associated_VBN with_IN insulin_NN deficiency_NN
          (_( Table_NNP 2_LS )_) ._. Streptozotocin_NNP injection_NN also_RB led_VBD to_TO
          significant_JJ hyperphagia_NN ,_, typical_JJ of_IN diabetic_JJ mice_NNS [_NN 17_CD ]_NN
          (_( Table_NNP 2_LS )_) ,_, and_CC adrenalectomy_NN also_RB ameliorated_JJ this_DT
          response_NN to_TO insulin_NN deficiency_NN (_( Table_NNP 2_LS )_) ._.
          Serum_NNP corticosterone_NN was_VBD elevated_VBD in_IN the_DT Sham-_NNP STZ_NNP
          group_NN and_CC was_VBD decreased_VBN in_IN both_DT ADX-STZ_NNP and_CC ADX-STZ-Fast_NNP
          groups_NNS (_( Fig_NNP ._. 3_LS A_DT )_) ._. Adrenalectomy_NNP did_VBD not_RB result_VB in_IN
          complete_JJ elimination_NN of_IN corticosterone_NN but_CC instead_RB
          resulted_VBD in_IN low_JJ but_CC detectable_JJ levels_NNS of_IN serum_NN
          corticosterone_NN as_RB previously_RB noted_VBD [_NN 9_CD ]_NN and_CC described_VBD
          above_IN ._. Serum_NNP insulin_NN was_VBD reduced_VBN to_TO the_DT same_JJ extent_NN in_IN
          Sham-_NNP STZ_NNP ,_, ADX-STZ_NNP ,_, and_CC in_IN ADX-STZ-Fast_NNP groups_NNS ,_, compared_VBN
          to_TO control_VB mice_NNS ,_, as_IN would_MD be_VB expected_VBN with_IN streptozotocin_NN
          injection_NN (_( Fig_NNP ._. 3_LS B_NNP )_) ._. Serum_NNP leptin_NN was_VBD also_RB reduced_VBN to_TO the_DT
          same_JJ levels_NNS in_IN all_DT experimental_JJ groups_NNS compared_VBN to_TO
          control_VB mice_NNS (_( Fig_NNP ._. 3_LS C_NNP )_) ._.
          Hypothalamic_NNP AGRP_NNP mRNA_NN was_VBD significantly_RB elevated_VBD in_IN
          sham-operated_JJ diabetic_JJ (_( vs_NNS ._. sham-operated_JJ euglycemic_JJ )_)
          mice_NNS as_IN expected_VBN [_NN 5_CD 17_CD ]_NN (_( Fig_NNP ._. 4_LS A_DT )_) ._. However_RB ,_,
          adrenalectomy_NN completely_RB blocked_VBD the_DT elevation_NN of_IN AGRP_NNP
          mRNA_NN in_IN diabetic_JJ mice_NNS whether_IN or_CC not_RB they_PRP were_VBD fasted_JJ
          (_( Fig_NNP ._. 4_LS A_DT )_) ._. Hypothalamic_NNP POMC_NNP mRNA_NN was_VBD reduced_VBN in_IN diabetic_JJ
          mice_NNS as_IN expected_VBN [_NN 5_CD 17_CD ]_NN (_( Fig_NNP ._. 4_LS B_NNP )_) ._. Adrenalectomy_NNP
          blocked_VBD this_DT reduction_NN in_IN POMC_NNP mRNA_NN in_IN diabetic_JJ mice_NNS
          whether_IN or_CC not_RB they_PRP were_VBD fasted_JJ (_( Fig_NNP ._. 4_LS B_NNP )_) ._. As_IN with_IN AGRP_NNP
          mRNA_NN ,_, NPY_NNP mRNA_NN was_VBD elevated_VBD in_IN diabetic_JJ mice_NNS ,_, and_CC
          adrenalectomy_NN blocked_VBD this_DT induction_NN of_IN NPY_NNP mRNA_NN in_IN
          diabetic_JJ mice_NNS whether_IN or_CC not_RB they_PRP were_VBD fasted_JJ (_( Fig_NNP ._. 4_LS C_NNP )_) ._.
          In_IN summary_NN ,_, hypothalamic_JJ AGRP_NNP ,_, POMC_NNP and_CC NPY_NNP mRNA_NN all_DT
          exhibited_VBN the_DT expected_VBN changes_NNS in_IN association_NN with_IN
          streptozotocin-induced_JJ diabetes_NN [_NN 5_CD 17_CD ]_NN (_( Fig_NNP ._. 4_LS A_DT ,_, 4_CD B_NNP ,_, 4_CD C_NNP )_) ,_,
          and_CC adrenalectomy_NN largely_RB or_CC completely_RB blocked_VBD all_PDT these_DT
          responses_NNS to_TO insulin_NN deficiency_NN whether_IN or_CC not_RB the_DT mice_NNS
          were_VBD fasted_JJ (_( Fig_NNP 4_CD A_DT ,_, 4_CD B_NNP ,_, 4_CD C_NNP )_) ._.
        
        
          Study_NNP 3_CD :_: Effects_NNPS of_IN corticosterone_NN implants_NNS on_IN
          hypothalamic_JJ gene_NN expression_NN
          Implantation_NNP of_IN corticosterone_NN implants_NNS for_IN 48_CD hours_NNS
          significantly_RB increased_VBN serum_NN corticosterone_NN ,_, compared_VBN to_TO
          placebo-implanted_JJ mice_NNS ,_, as_IN expected_VBN (_( Fig_NNP ._. 5_LS A_DT )_) ._.
          Interestingly_RB ,_, the_DT corticosterone_NN implants_NNS also_RB
          significantly_RB increased_VBN serum_NN insulin_NN and_CC leptin_NN (_( Fig_NNP ._.
          5_LS Band_NNP 5_CD C_NNP )_) ._. In_IN contrast_NN ,_, the_DT corticosterone_NN implants_NNS did_VBD
          not_RB significantly_RB influence_VB body_NN weight_NN or_CC food_NN intake_NN
          compared_VBN to_TO placebo-implanted_JJ mice_NNS (_( body_NN weight_NN of_IN 24_CD ._. 5_LS ±_NN
          0_CD ._. 6_CD g_SYM for_IN the_DT placebo_NN group_NN compared_VBN to_TO 24_CD ._. 4_LS ±_NN 0_CD ._. 6_CD g_SYM for_IN
          the_DT corticosterone_NN implant_VB group_NN ;_: food_NN intake_NN of_IN 4_CD ._. 3_CD ±_NN
          0_CD ._. 1_CD g_SYM /_NN day_NN for_IN the_DT placebo_NN group_NN compared_VBN to_TO 4_CD ._. 1_CD ±_NN 0_CD ._. 5_CD
          g_SYM /_NN day_NN for_IN the_DT corticosterone_NN implant_VB group_NN )_) ,_, although_IN
          epididymal_NN adipose_NN tissue_NN depot_NN was_VBD slightly_RB smaller_JJR in_IN
          the_DT corticosterone_NN implant_VB group_NN (_( 0_CD ._. 19_CD ±_NN 0_CD ._. 01_CD g_SYM for_IN the_DT
          placebo_NN group_NN compared_VBN to_TO 0_CD ._. 15_CD ±_NN 0_CD ._. 01_CD g_SYM for_IN the_DT
          corticosterone_NN implant_VB group_NN ;_: p_NN <_NN 0_CD ._. 05_CD )_) ._.
          Corticosterone_NNP implants_NNS also_RB had_VBD no_DT influence_NN on_IN blood_NN
          glucose_NN (_( 134_CD ._. 8_CD ±_NN 10_CD ._. 9_CD mg_NN /_NN dl_NN for_IN the_DT placebo_NN group_NN
          compared_VBN to_TO 128_CD ._. 8_CD ±_NN 4_CD ._. 3_CD mg_NN /_NN dl_NN for_IN the_DT corticosterone_NN
          implant_VB group_NN )_) ._.
          Implantation_NNP of_IN corticosterone_NN implants_NNS for_IN 48_CD hours_NNS
          significantly_RB elevated_VBD hypothalamic_JJ AGRP_NNP expression_NN
          compared_VBN to_TO the_DT placebo_NN group_NN (_( Fig_NNP ._. 6_CD A_DT )_) ._. Hypothalamic_NNP
          POMC_NNP mRNA_NN was_VBD also_RB significantly_RB elevated_VBD in_IN the_DT
          corticosterone_NN implant_VB group_NN (_( Fig_NNP ._. 6_CD B_NNP )_) ._. Hypothalamic_NNP NPY_NNP
          mRNA_NN exhibited_VBN a_DT trend_NN toward_IN an_DT increase_NN although_IN the_DT
          effect_NN was_VBD not_RB significant_JJ (_( p_NN =_SYM 0_CD ._. 14_CD ;_: Fig_NNP ._. 6_CD C_NNP )_) ._. Therefore_RB
          hypothalamic_JJ AGRP_NNP and_CC POMC_NNP mRNAs_NNS were_VBD both_DT induced_VBN by_IN the_DT
          glucocorticoid_NN implant_VB ,_, whereas_IN the_DT NPY_NNP mRNA_NN was_VBD not_RB
          significantly_RB influenced_VBN ._.
        
      
      
        Conclusions_NNP
        In_IN the_DT present_JJ study_NN ,_, adrenalectomy_NN and_CC corticosterone_NN
        implants_NNS were_VBD used_VBN to_TO address_VB the_DT role_NN of_IN elevated_JJ
        corticosterone_NN in_IN mediating_VBG the_DT effects_NNS of_IN fasting_VBG and_CC
        insulin_NN deficiency_NN on_IN hypothalamic_JJ gene_NN expression_NN ,_,
        resulting_VBG in_IN several_JJ novel_NN observations_NNS ._. First_LS ,_, we_PRP have_VBP
        demonstrated_VBN that_DT adrenalectomy_NN can_MD block_VB the_DT elevation_NN of_IN
        AGRP_NNP mRNA_NN and_CC the_DT reduction_NN in_IN POMC_NNP mRNA_NN with_IN fasting_VBG ,_,
        consistent_JJ with_IN previous_JJ findings_NNS by_IN Ponsalle_NNP et_CC al_NN ._.
        concerning_VBG NPY_NNP [_NN 14_CD ]_NN ,_, and_CC suggesting_VBG that_IN increases_NNS in_IN
        corticosterone_NN mediate_VB fasting-induced_JJ changes_NNS in_IN
        melanocortin_NN tone_NN ._. Second_JJ ,_, we_PRP have_VBP also_RB shown_VBN that_IN
        hypothalamic_JJ responses_NNS to_TO insulin_NN deficiency_NN require_VB
        elevation_NN in_IN corticosterone_NN ._. Third_NNP ,_, we_PRP have_VBP demonstrated_VBN
        using_VBG corticosterone_NN implants_NNS ,_, that_WDT elevated_JJ corticosterone_NN
        is_VBZ sufficient_JJ to_TO enhance_VB hypothalamic_JJ AGRP_NNP expression_NN ,_, but_CC
        not_RB to_TO reduce_VB hypothalamic_JJ POMC_NNP mRNA_NN ._. Together_RB these_DT
        results_NNS suggest_VBP that_IN an_DT elevation_NN of_IN corticosterone_NN is_VBZ
        necessary_JJ for_IN reduction_NN in_IN melanocortin_NN tone_NN during_IN fasting_VBG
        and_CC with_IN diabetes_NN and_CC is_VBZ sufficient_JJ to_TO induce_VB hypothalamic_JJ
        AGRP_NNP mRNA_NN but_CC not_RB to_TO reduce_VB POMC_NNP expression_NN ._.
        Although_IN a_DT reduction_NN in_IN plasma_NN leptin_NN plays_VBZ an_DT important_JJ
        role_NN in_IN mediating_VBG neuroendocrine_NN responses_NNS to_TO fasting_VBG [_NN 6_CD ]_NN
        and_CC diabetes_NN [_NN 17_CD ]_NN ,_, we_PRP have_VBP previously_RB demonstrated_VBN that_IN
        fasting_VBG can_MD regulate_VB hypothalamic_JJ melanocortin_NN tone_NN
        independently_RB of_IN both_DT leptin_NN and_CC insulin_NN [_NN 5_CD ]_NN ._. The_DT
        present_JJ studies_NNS suggest_VBP that_DT corticosterone_NN may_MD play_VB a_DT role_NN
        in_IN mediating_VBG these_DT leptin-independent_JJ effects_NNS ._. Fasting_NNP was_VBD
        associated_VBN with_IN elevated_JJ corticosterone_NN (_( Fig_NNP ._. 1_LS A_DT )_) and_CC
        reduced_VBN insulin_NN and_CC leptin_NN (_( Fig_NNP ._. 1_LS Band_NNP 1_CD C_NNP )_) as_RB well_RB as_IN
        melanocortin_NN tone_NN (_( Fig_NNP ._. 2_LS Aand_NNP 2_CD B_NNP )_) as_IN expected_VBN ._. However_RB ,_,
        preventing_VBG the_DT elevation_NN of_IN corticosterone_NN completely_RB
        blocked_VBD the_DT effect_NN of_IN fasting_VBG on_IN hypothalamic_JJ AGRP_NNP and_CC POMC_NNP
        mRNA_NN (_( Fig_NNP ._. 2_LS Aand_NNP 2_CD B_NNP )_) ,_, without_IN preventing_VBG effects_NNS of_IN fasting_VBG
        on_IN plasma_NN leptin_NN or_CC insulin_NN ._. Adrenalectomy_NNP also_RB blocked_VBD the_DT
        effects_NNS of_IN fasting_VBG on_IN hypothalamic_JJ NPY_NNP mRNA_NN (_( Fig_NNP ._. 2_LS C_NNP )_) ,_,
        confirming_VBG the_DT findings_NNS of_IN Ponsalle_NNP et_CC al_NN ._. [_NN 14_CD ]_NN ._. These_DT
        data_NNS suggest_VBP that_DT leptin_NN 's_POS effect_NN to_TO reverse_VB effects_NNS of_IN
        fasting_VBG on_IN melanocortin_NN tone_NN may_MD require_VB and_CC be_VB mediated_JJ by_IN
        a_DT reduction_NN in_IN glucocorticoids_NNS ._.
        Glucocorticoids_NNP were_VBD also_RB elevated_VBD ,_, as_IN expected_VBN ,_, in_IN
        insulin-deficient_JJ diabetes_NN (_( Fig_NNP ._. 3_LS A_DT )_) ,_, and_CC serum_NN insulin_NN ,_,
        leptin_NN and_CC melanocortin_NN tone_NN were_VBD also_RB reduced_VBN in_IN this_DT
        condition_NN (_( Fig_NNP ._. 3_LS Band_NNP 3_CD C_NNP ,_, 4_CD Aand_NNP 4_CD B_NNP )_) ._. As_IN with_IN fasting_VBG ,_, the_DT
        reduction_NN in_IN plasma_NN leptin_NN could_MD largely_RB be_VB a_DT reflection_NN of_IN
        the_DT reduction_NN in_IN adipose_NN weight_NN ,_, as_RB well_RB as_IN plasma_NN insulin_NN ._.
        In_IN turn_NN ,_, as_IN with_IN fasting_VBG ,_, the_DT reduction_NN of_IN plasma_NN leptin_NN
        could_MD be_VB the_DT cause_NN of_IN the_DT elevation_NN of_IN hypothalamic_JJ AGRP_NNP
        and_CC NPY_NNP mRNA_NN ,_, as_RB well_RB as_IN the_DT reduction_NN of_IN hypothalamic_JJ POMC_NNP
        mRNA_NN ._. On_IN the_DT other_JJ hand_NN ,_, blocking_VBG the_DT rise_NN in_IN
        corticosterone_NN by_IN adrenalectomy_NN prevented_VBD the_DT reduction_NN in_IN
        hypothalamic_JJ POMC_NNP mRNA_NN and_CC the_DT induction_NN of_IN AGRP_NNP mRNA_NN ,_,
        without_IN reversing_VBG either_DT the_DT reduced_VBN leptin_NN or_CC the_DT reduced_VBN
        adiposity_NN ,_, characteristic_NN of_IN insulin-deficient_JJ diabetic_JJ
        mice_NNS (_( Fig_NNP ._. 4_LS Aand_NNP 4_CD B_NNP )_) ._. These_DT data_NNS suggest_VBP that_DT reversal_NN of_IN
        effects_NNS of_IN insulin_NN deficiency_NN by_IN leptin_NN [_NN 7_CD ]_NN may_MD require_VB
        and_CC be_VB mediated_JJ by_IN a_DT reduction_NN in_IN glucocorticoids_NNS ._. We_PRP had_VBD
        previously_RB shown_VBN that_IN fasting_VBG could_MD regulate_VB hypothalamic_JJ
        gene_NN expression_NN in_IN insulin-deficient_JJ mice_NNS even_RB though_IN in_IN
        these_DT mice_NNS fasting_VBG did_VBD not_RB influence_VB plasma_NN leptin_NN or_CC
        insulin_NN [_NN 5_CD ]_NN ._. Since_IN adrenalectomy_NN blocked_VBD the_DT
        fasting-induced_JJ reduction_NN in_IN melanocortin_NN tone_NN in_IN diabetic_JJ
        mice_NNS (_( as_IN it_PRP had_VBD in_IN euglycemic_JJ mice_NNS in_IN the_DT first_JJ study_NN )_) ,_,
        these_DT results_NNS suggest_VBP that_IN effects_NNS of_IN fasting_VBG on_IN
        melanocortin_NN tone_NN in_IN diabetic_JJ mice_NNS may_MD be_VB mediated_JJ at_IN least_JJS
        in_IN part_NN by_IN a_DT rise_NN in_IN plasma_NN corticosterone_NN (_( itself_PRP possibly_RB
        secondary_JJ to_TO the_DT reduction_NN in_IN plasma_NN leptin_NN )_) ._.
        Implanting_NNP corticosterone_NN implants_NNS for_IN 48_CD hours_NNS led_VBN to_TO
        an_DT elevation_NN in_IN both_DT hypothalamic_JJ AGRP_NNP and_CC POMC_NNP mRNA_NN (_( Fig_NNP ._.
        6_CD B_NNP )_) ._. Since_IN adrenalectomy_NN blocked_VBD the_DT elevation_NN of_IN AGRP_NNP mRNA_NN
        by_IN fasting_VBG and_CC insulin_NN deficiency_NN ,_, elevation_NN of_IN
        corticosterone_NN would_MD be_VB expected_VBN to_TO increase_VB hypothalamic_JJ
        AGRP_NNP mRNA_NN ,_, as_IN was_VBD indeed_RB observed_VBN ._. However_RB ,_, the_DT
        corticosterone_NN implants_NNS produced_VBD the_DT unexpected_JJ effect_NN of_IN
        elevating_VBG hypothalamic_JJ POMC_NNP mRNA_NN ,_, a_DT rare_JJ if_IN not_RB unique_JJ
        circumstance_NN in_IN which_WDT hypothalamic_JJ AGRP_NNP and_CC POMC_NNP mRNA_NN are_VBP
        regulated_VBN in_IN the_DT same_JJ direction_NN ._. The_DT basis_NN of_IN this_DT
        unexpected_JJ phenomenon_NN is_VBZ not_RB yet_RB clear_JJ ._. However_RB ,_, since_IN
        leptin_NN and_CC insulin_NN both_DT stimulate_VB hypothalamic_JJ POMC_NNP [_NN 18_CD ]_NN
        ,_, the_DT elevation_NN of_IN insulin_NN and_CC leptin_NN in_IN the_DT
        corticosterone-implanted_JJ mice_NNS (_( Fig_NNP ._. 5_LS Band_NNP 5_CD C_NNP )_) ,_, the_DT former_NN
        possibly_RB mediated_JJ by_IN glucocorticoid-induced_JJ insulin_NN
        resistance_NN and_CC the_DT latter_NN possibly_RB mediated_JJ by_IN the_DT
        resulting_VBG hyperinsulinemia_NN ,_, might_MD mediate_VB the_DT observed_VBN
        effect_NN of_IN corticosterone_NN implants_NNS on_IN hypothalamic_JJ POMC_NNP in_IN
        these_DT implanted_VBN mice_NNS ._. On_IN the_DT other_JJ hand_NN ,_, leptin_NN inhibits_NNS
        hypothalamic_JJ AGRP_NNP mRNA_NN [_NN 4_CD ]_NN ,_, yet_RB AGRP_NNP mRNA_NN was_VBD
        nevertheless_RB elevated_VBD in_IN the_DT face_NN of_IN elevated_JJ insulin_NN and_CC
        leptin_NN ._. These_DT data_NNS suggest_VBP that_IN in_IN fasting_VBG and_CC
        insulin-deficient_JJ diabetes_NN ,_, as_IN in_IN leptin-deficient_JJ 
        ob_NN /_NN ob_NN mice_NNS [_NN 9_CD 19_CD ]_NN ,_, glucocorticoids_NNS
        dominate_VBP leptin_NN and_CC insulin_NN levels_NNS in_IN determining_VBG AGRP_NNP
        expression_NN ,_, whereas_IN insulin_NN and_CC leptin_NN dominate_VB
        glucocorticoids_NNS in_IN determining_VBG hypothalamic_JJ POMC_NNP
        expression_NN ._. These_DT data_NNS are_VBP also_RB consistent_JJ with_IN the_DT
        observation_NN that_IN in_IN streptozotocin-induced_JJ diabetic_JJ rats_NNS ,_,
        replacement_NN of_IN insulin_NN is_VBZ not_RB sufficient_JJ to_TO normalize_VB
        elevated_VBD serum_NN corticosterone_NN or_CC the_DT elevated_VBD hypothalamic_JJ
        AGRP_NNP mRNA_NN while_IN it_PRP does_VBZ partially_RB normalize_VB plasma_NN leptin_NN
        and_CC hypothalamic_JJ POMC_NNP mRNA_NN [_NN 17_CD ]_NN ._.
        After_IN the_DT present_JJ paper_NN was_VBD submitted_VBN for_IN review_NN ,_, we_PRP
        became_VBD aware_JJ of_IN a_DT recent_JJ study_NN by_IN Savontaus_NNP et_CC al_NN ._.
        examining_VBG the_DT role_NN of_IN glucocorticoids_NNS in_IN the_DT regulation_NN of_IN
        hypothalamic_JJ gene_NN expression_NN in_IN rats_NNS [_NN 20_CD ]_NN ,_, using_VBG a_DT
        roughly_RB similar_JJ experimental_JJ design_NN as_IN in_IN the_DT present_JJ
        study_NN ._. In_IN several_JJ respects_VBZ the_DT conclusions_NNS from_IN this_DT study_NN
        are_VBP similar_JJ to_TO the_DT present_JJ study_NN (_( for_IN example_NN ,_,
        corticoisterone_NN implants_NNS increased_VBD hypothalamic_JJ AGRP_NNP and_CC
        POMC_NNP mRNA_NN ,_, and_CC adrenalectomy_NN blocked_VBD the_DT effect_NN of_IN fasting_VBG
        on_IN hypothalamic_JJ POMC_NNP mRNA_NN )_) ._. However_RB ,_, in_IN one_CD key_JJ respect_NN the_DT
        results_NNS reported_VBN by_IN Savontaus_NNP et_CC al_NN ._. differed_VBD from_IN those_DT in_IN
        the_DT present_JJ paper_NN :_: adrenalectomy_NN failed_VBD to_TO block_VB the_DT
        effects_NNS of_IN fasting_VBG on_IN hypothalamic_JJ AGRP_NNP and_CC NPY_NNP ,_, even_RB
        though_IN corticosterone_NN implants_NNS were_VBD observed_VBN to_TO induce_VB AGRP_NNP
        mRNA_NN ._. Since_IN we_PRP observed_VBD that_DT adrenalectomy_NN also_RB blocks_VBZ the_DT
        effects_NNS of_IN diabetes_NN on_IN hypothalamic_JJ gene_NN expression_NN in_IN the_DT
        present_JJ study_NN ,_, we_PRP suspect_VBP the_DT difference_NN between_IN the_DT
        present_JJ study_NN and_CC that_IN of_IN Savontaus_NNP et_CC al_NN ._. is_VBZ probably_RB due_JJ
        to_TO different_JJ regulatory_JJ requirements_NNS in_IN mice_NNS and_CC rats_NNS ._. For_IN
        example_NN ,_, it_PRP is_VBZ clear_JJ that_IN the_DT regulation_NN of_IN AGRP_NNP differs_VBZ in_IN
        rats_NNS and_CC mice_NNS ,_, since_IN in_IN mice_NNS hypothalamic_JJ AGRP_NNP mRNA_NN is_VBZ
        elevated_VBD by_IN a_DT deficiency_NN in_IN leptin_NN receptor_NN function_NN [_NN 4_CD ]_NN
        but_CC in_IN rats_NNS this_DT is_VBZ not_RB true_JJ [_NN 21_CD ]_NN ._. However_RB ,_, hypothalamic_JJ
        POMC_NNP is_VBZ regulated_VBN similarly_RB in_IN rats_NNS and_CC mice_NNS ,_, and_CC this_DT is_VBZ
        probably_RB the_DT more_RBR important_JJ element_NN regulating_VBG metabolic_JJ
        phenotype_NN ._.
        Taken_VBN together_RB ,_, these_DT data_NNS suggest_VBP that_WDT elevated_VBD
        glucocorticoids_NNS are_VBP sufficient_JJ to_TO drive_VB the_DT increase_NN in_IN
        hypothalamic_JJ AGRP_NNP mRNA_NN during_IN fasting_VBG and_CC diabetes_NN but_CC not_RB
        the_DT reduction_NN in_IN POMC_NNP mRNA_NN ._. Interestingly_RB ,_, at_IN least_JJS with_IN
        respect_NN to_TO food_NN intake_NN and_CC body_NN weight_NN over_IN this_DT 48_CD -_: hour_NN
        period_NN ,_, the_DT elevation_NN of_IN POMC_NNP appears_VBZ to_TO compensate_VB for_IN the_DT
        elevation_NN in_IN AGRP_NNP to_TO produce_VB no_DT net_JJ functional_JJ effect_NN on_IN
        body_NN weight_NN homeostasis_NNS in_IN the_DT presence_NN of_IN significantly_RB
        elevated_VBD plasma_NN corticosterone_NN ._. After_IN more_RBR chronic_JJ
        exposure_NN ,_, this_DT delicate_JJ balance_NN could_MD plausibly_RB become_VB
        disrupted_VBN ,_, leading_VBG to_TO glucocorticoid-mediated_JJ development_NN
        of_IN the_DT metabolic_JJ syndrome_NN [_NN 10_CD ]_NN ._. Thus_RB interactions_NNS
        between_IN insulin_NN ,_, leptin_NN ,_, and_CC glucocorticoids_NNS ,_, and_CC the_DT
        neuropeptide_NN responses_NNS they_PRP generate_VBP within_IN the_DT
        melanocortin_NN system_NN ,_, allow_VB complex_JJ metabolic_JJ responses_NNS to_TO
        nutritional_JJ status_NN but_CC may_MD also_RB allow_VB the_DT development_NN of_IN
        metabolic_JJ pathologies_NNS ._.
      
      
        Methods_NNP
        
          Animals_NNS
          The_DT appropriate_JJ Institutional_NNP Animal_NNP Review_NNP Board_NNP had_VBD
          approved_VBN all_DT studies_NNS ._.
          To_TO study_VB the_DT effect_NN of_IN adrenalectomy_NN on_IN
          fasting-induced_JJ changes_NNS in_IN hypothalamic_JJ gene_NN expression_NN
          (_( Study_NNP 1_LS )_) ,_, two_CD month-old_JJ male_JJ C_NNP 57_CD Bl_NNP /_NN 6_CD J_NNP mice_NNS were_VBD obtained_VBN
          from_IN The_DT Jackson_NNP Laboratory_NNP (_( Bar_NNP Harbor_NNP ,_, ME_NNP )_) ._. Mice_NNS were_VBD
          individually_RB housed_VBN with_IN free_JJ access_NN to_TO food_NN and_CC water_NN
          under_IN 12_CD :_: 12_CD h_NN light-dark_JJ cycle_NN (_( lights_NNS on_IN at_IN 07_CD :_: 00_CD h_NN )_) ._. Of_IN
          the_DT 31_CD mice_NNS ,_, 19_CD mice_NNS were_VBD adrenalectomized_JJ and_CC the_DT rest_NN
          underwent_VBD a_DT sham_NN operation_NN ._. Adrenalectomy_NNP was_VBD performed_VBN ,_,
          as_IN described_VBN previously_RB ,_, by_IN bilateral_JJ flank_NN incision_NN
          under_IN anesthesia_NN (_( 2_CD ._. 5_LS %_NN 2_CD -_: 2_CD -_: 2_CD -_: tribromoethanol_NN ,_, 0_CD ._. 015_CD -_: 0_CD ._. 017_CD
          ml_NN /_NN g_SYM body_NN weight_NN ,_, i_NNP ._. p_NN ._. )_) [_NN 9_CD ]_NN ._. Sham_NNP adrenalectomy_NN
          entailed_VBN the_DT same_JJ procedure_NN as_IN adrenalectomy_NN ,_, except_IN that_IN
          the_DT adrenal_NN glands_NNS were_VBD grasped_JJ but_CC not_RB removed_VBN ._. After_IN
          the_DT surgery_NN all_DT mice_NNS were_VBD given_VBN one_CD injection_NN of_IN
          dexamethasone_NN (_( 45_CD mg_NN /_NN kg_NN b_SYM ._. w_NN ._. i_NNP ._. p_NN ._. )_) to_TO facilitate_VB recovery_NN
          from_IN surgery_NN ._. The_DT drinking_NN water_NN was_VBD replaced_VBN with_IN normal_JJ
          saline_NN (_( 0_CD ._. 9_CD %_NN NaCl_NNP )_) to_TO compensate_VB for_IN the_DT loss_NN of_IN
          mineralocorticoids_NNS ._. Body_NN weight_NN was_VBD monitored_VBN for_IN one_CD
          week_NN following_VBG the_DT operation_NN at_IN which_WDT time_NN it_PRP was_VBD
          verified_VBN that_IN the_DT animals_NNS had_VBD recovered_VBN initial_JJ body_NN
          weight_NN as_IN expected_VBN ._. All_DT mice_NNS were_VBD placed_VBN in_IN fresh_JJ cages_NNS
          with_IN new_JJ bedding_NN ,_, and_CC food_NN was_VBD removed_VBN from_IN half_NN of_IN the_DT
          adrenalectomized_JJ mice_NNS and_CC half_NN of_IN the_DT sham_NN operated_VBD mice_NNS
          for_IN 48_CD hours_NNS ._. This_DT resulted_VBD in_IN four_CD groups_NNS ;_: sham_NN ad_NN lib_NN
          fed_VBN (_( n_NN =_SYM 6_CD )_) ,_, sham_NN 48_CD hour_NN fast_RB (_( n_NN =_SYM 6_CD )_) ,_, adrenalectomized_JJ
          ad_NN lib_NN fed_VBN (_( n_NN =_SYM 10_CD )_) and_CC adrenalectomized_JJ 48_CD hour_NN fast_RB (_( n_NN
          =_SYM 9_CD )_) ._.
          To_TO study_VB the_DT effects_NNS of_IN adrenalectomy_NN ,_, insulin_NN
          deficiency_NN and_CC fasting_VBG (_( Study_NNP 2_LS )_) 33_CD male_JJ C_NNP 57_CD Bl_NNP /_NN 6_CD J_NNP mice_NNS
          were_VBD obtained_VBN at_IN 2_CD months_NNS of_IN age_NN from_IN The_DT Jackson_NNP
          Laboratory_NNP (_( Bar_NNP Harbor_NNP ,_, ME_NNP )_) and_CC were_VBD individually_RB housed_VBN
          with_IN free_JJ access_NN to_TO feed_VB and_CC water_NN under_IN 12_CD :_: 12_CD h_NN
          light-dark_JJ cycle_NN as_IN described_VBN above_IN ._. Mice_NNS were_VBD treated_VBN
          with_IN daily_JJ injections_NNS of_IN dexamethasone_NN (_( 45_CD mg_NN /_NN kg_NN body_NN
          weight_NN i_NNP ._. p_NN ._. )_) for_IN three_CD weeks_NNS during_IN which_WDT time_NN they_PRP were_VBD
          either_CC adrenalectomized_JJ or_CC sham_NN operated_VBN as_IN described_VBN
          above_IN ._. Half_PDT the_DT sham-operated_JJ and_CC all_PDT the_DT
          adrenalectomized_JJ mice_NNS were_VBD injected_VBN with_IN streptozotocin_NN
          10_CD days_NNS after_IN the_DT surgery_NN (_( 160_CD mg_NN /_NN kg_NN body_NN weight_NN ;_: freshly_RB
          purchased_VBN from_IN Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP and_CC dissolved_VBN in_IN 25_CD
          mM_NN Citric_NNP Acid_NNP Buffer_NNP pH_NN =_SYM 4_CD ._. 5_LS )_) while_IN the_DT rest_NN received_VBD
          buffer_NN alone_RB by_IN tail_NN vein_NN injection_NN 10_CD days_NNS after_IN
          surgery_NN ._. Dexamethasone_NNP treatment_NN continued_VBD until_IN four_CD
          days_NNS after_IN the_DT streptozotocin_NN injection_NN ._. Mice_NNS were_VBD then_RB
          monitored_VBN for_IN two_CD weeks_NNS without_IN the_DT dexamethasone_NN
          injection_NN at_IN which_WDT point_VBP half_PDT the_DT adrenalectomized-_NN STZ_NNP
          treated_VBD group_NN were_VBD fasted_JJ while_IN the_DT rest_NN of_IN the_DT mice_NNS were_VBD
          ad_NN lib_NN fed_VBN ._. This_DT resulted_VBD in_IN four_CD separate_JJ groups_NNS :_:
          sham-operated-buffer-injected-ad_JJ lib_NN fed_VBN (_( control_NN ;_: n_NN =_SYM
          9_CD )_) ,_, sham-operated-streptozotocin-injected-ad_JJ lib_NN fed_VBN
          (_( sham-_NN STZ_NNP ;_: n_NN =_SYM 8_CD )_) ,_,
          adrenalectomized-streptozotocin-injected-ad_JJ lib_NN fed_VBN
          (_( ADX-STZ_NNP ;_: n_NN =_SYM 11_CD )_) and_CC
          adrenalectomized-streptozotocin-injected-fasted_JJ mice_NNS
          (_( ADX-STZ-Fast_NNP ;_: n_NN =_SYM 5_LS )_) ._.
          To_TO study_VB the_DT direct_JJ effects_NNS of_IN corticosterone_NN (_( Study_NNP
          3_LS )_) ,_, a_DT corticosterone_NN implant_VB study_NN was_VBD conducted_VBN with_IN 16_CD
          C_NNP 57_CD Bl_NNP /_NN 6_CD J_NNP retired_VBD breeders_NNS also_RB obtained_VBN from_IN The_DT Jackson_NNP
          Laboratories_NNPS (_( Bar_NNP Harbor_NNP ,_, ME_NNP )_) ._. As_IN with_IN the_DT first_JJ and_CC
          second_JJ studies_NNS ,_, mice_NNS were_VBD individually_RB housed_VBN with_IN free_JJ
          access_NN to_TO food_NN and_CC water_NN under_IN 12_CD :_: 12_CD h_NN light-dark_JJ cycle_NN
          (_( lights_NNS on_IN at_IN 07_CD :_: 00_CD h_NN )_) ._. Mice_NNS were_VBD divided_VBN into_IN two_CD group_NN :_:
          one_CD received_VBD corticosterone_NN implants_NNS of_IN 30_CD mg_NN (_( Innovative_JJ
          Research_NNP of_IN America_NNP ,_, Sarasota_NNP ,_, FL_NNP )_) (_( n_NN =_SYM 8_CD )_) ,_, while_IN the_DT
          other_JJ mice_NNS received_VBD placebo_NN implants_NNS (_( Innovative_JJ Research_NNP
          of_IN America_NNP ,_, Sarasota_NNP ,_, FL_NNP )_) (_( n_NN =_SYM 8_CD )_) ._. Body_NN weight_NN and_CC food_NN
          intake_NN were_VBD monitored_VBN for_IN 48_CD hours_NNS after_IN which_WDT time_NN all_PDT
          the_DT mice_NNS were_VBD sacrificed_JJ ._.
          For_IN all_DT studies_NNS ,_, mice_NNS were_VBD sacrificed_JJ following_NN a_DT
          balanced_JJ design_NN towards_IN the_DT end_NN of_IN the_DT light_JJ period_NN
          (_( between_IN 17_CD :_: 00_CD and_CC 18_CD :_: 30_CD h_NN )_) ._. Mice_NNS were_VBD decapitated_JJ
          decapitation_NN after_IN a_DT brief_JJ (_( approximately_RB 45_CD second_JJ )_)
          exposure_NN to_TO carbon_NN dioxide_NN ;_: we_PRP have_VBP verified_VBN in_IN pilot_NN
          studies_NNS that_IN the_DT brief_JJ exposure_NN to_TO carbon_NN dioxide_NN does_VBZ
          not_RB significantly_RB affect_VB the_DT plasma_NN corticosterone_NN levels_NNS
          under_IN these_DT conditions_NNS (_( Table_NNP 3_LS )_) ._. Adrenalectomy_NNP was_VBD
          verified_VBN in_IN each_DT individual_NN by_IN visual_JJ inspection_NN to_TO
          assure_VB that_IN no_DT visible_JJ traces_NNS of_IN the_DT adrenal_NN glands_NNS were_VBD
          observed_VBN ._. Brains_NNP for_IN Northern_NNP blot_NN analysis_NN were_VBD quickly_RB
          removed_VBN and_CC the_DT hypothalamus_JJ was_VBD dissected_VBN out_IN ,_, frozen_VBN on_IN
          dry_JJ ice_NN ,_, and_CC stored_VBD at_IN -_: 70_CD °_NN C_NNP until_IN use_NN ._. Epididymal_NNP white_JJ
          adipose_NN tissue_NN was_VBD also_RB removed_VBN ,_, weighed_VBD ,_, and_CC frozen_VBN on_IN
          dry_JJ ice_NN ,_, and_CC stored_VBD at_IN -_: 70_CD °_NN C_NNP until_IN use_NN ._.
        
        
          Blood_NNP chemistry_NN
          Blood_NNP glucose_NN was_VBD measured_VBN by_IN a_DT Lifescan_NNP One-_NNP Touch_NNP II_NNP
          glucose_NN meter_NN (_( Johnson_NNP &_CC Johnson_NNP ,_, Mountain_NNP View_NNP ,_, CA_NNP )_) ._.
          Serum_NNP insulin_NN and_CC leptin_NN were_VBD assayed_JJ by_IN an_DT enzyme-linked_JJ
          immunosorbent_NN assay_NN (_( ELISA_NNP )_) with_IN commercial_JJ kits_NNS (_( CRYSTAL_NNP
          CHEM_NNP INC_NNP ._. ,_, Chicago_NNP ,_, IL_NNP )_) and_CC serum_NN corticosterone_NN was_VBD
          assayed_JJ by_IN radio_NN immunoassay_NN (_( RIA_NNP )_) with_IN commercial_JJ kits_NNS
          (_( ICN_NNP Biomedicals_NNP Inc_NNP ._. ,_, Costa_NNP Mesa_NNP CA_NNP )_) ._.
        
        
          RNA_NNP analysis_NN
          Total_NNP RNA_NNP was_VBD extracted_VBN from_IN tissue_NN using_VBG TRIzol_NNP
          (_( GIBCO_NNP BRL_NNP ,_, Gaithersburg_NNP ,_, MD_NNP )_) ._. Five_CD micrograms_NNS of_IN total_JJ
          RNA_NNP from_IN hypothalamus_JJ was_VBD subjected_VBN to_TO Northern_NNP blot_NN
          analysis_NN ,_, as_IN described_VBN previously_RB ,_, to_TO measure_VB POMC_NNP ,_, AGRP_NNP
          and_CC NPY_NNP mRNA_NN [_NN 3_CD 4_CD 5_CD 9_CD ]_NN ._. Seven_CD micrograms_NNS of_IN total_JJ RNA_NNP
          from_IN adipose_NN tissue_NN was_VBD also_RB subjected_VBN to_TO Northern_NNP blot_NN
          analysis_NN to_TO measure_VB leptin_NN mRNA_NN ._. The_DT blots_NNS were_VBD probed_JJ
          with_IN single-stranded_JJ internally_RB labeled_VBN DNA_NNP probes_NNS as_IN
          described_VBN previously_RB [_NN 16_CD ]_NN ._. To_TO monitor_VB RNA_NNP loading_NN ,_,
          membranes_NNS were_VBD re-probed_JJ and_CC hybridized_JJ with_IN a_DT
          32_CD P-_NNP labeled_VBD probe_NN encoding_VBG 18_CD S_NNP ribosomal_JJ RNA_NNP ._. The_DT total_JJ
          integrated_VBN densities_NNS of_IN hybridization_NN signals_NNS were_VBD
          determined_VBN by_IN phosphoimager_NN (_( STORM_NNP 860_CD ,_, Molecular_NNP
          Dynamics_NNP ,_, Sunnyvale_NNP ,_, CA_NNP )_) ._.
        
        
          Statistical_NNP analysis_NN
          For_IN the_DT first_JJ study_NN ,_, statistical_JJ analysis_NN entailed_VBN a_DT
          two-way_JJ analysis_NN of_IN variance_NN (_( ANOVA_NNP )_) followed_VBN ,_, when_WRB
          indicated_VBN by_IN appropriate_JJ p-values_JJ (_( p_NN <_NN 0_CD ._. 05_CD )_) ,_, by_IN
          Tukey-_NNP Kramer_NNP post-hoc_JJ test_NN ,_, using_VBG the_DT JMP_NNP statistical_JJ
          package_NN implemented_VBN on_IN the_DT Macintosh_NNP operating_VBG system_NN ._.
          For_IN the_DT second_JJ study_NN a_DT one-way_JJ analysis_NN of_IN variance_NN was_VBD
          performed_VBN and_CC followed_VBN ,_, when_WRB indicated_VBN by_IN appropriate_JJ
          p-values_JJ (_( p_NN <_NN 0_CD ._. 05_CD )_) ,_, by_IN Tukey-_NNP Kramer_NNP post-hoc_JJ test_NN
          using_VBG the_DT JMP_NNP statistical_JJ package_NN ._. For_IN the_DT third_JJ study_NN
          unpaired_JJ t-tests_JJ were_VBD carried_VBN out_IN using_VBG the_DT JMP_NNP
          statistical_JJ package_NN ._. A_DT p-value_JJ of_IN less_JJR than_IN 0_CD ._. 05_CD was_VBD
          considered_VBN significant_JJ ._.
        
      
      
        Authors_NNP '_'' contributions_NNS
        Author_NN 1_CD (_( HM_NNP )_) carried_VBD out_RP the_DT animal_NN work_NN ,_, the_DT mRNA_NN
        analysis_NN ,_, and_CC the_DT statistical_JJ analysis_NN and_CC drafted_VBD the_DT
        manuscript_NN ._. Author_NN 2_CD (_( TMM_NNP )_) assisted_VBN in_IN animal_NN surgeries_NNS ._.
        Author_NN 3_CD (_( FI_NNP )_) carried_VBD out_RP the_DT tail_NN vein_NN injections_NNS in_IN the_DT
        2_CD nd_NN study_NN ._. Author_NN 4_CD (_( JB_NNP )_) carried_VBD out_RP all_PDT the_DT hormones_NNS
        assays_NNS ._. Author_NN 5_CD (_( JHS_NNP )_) contributed_VBD to_TO the_DT hormone_NN assays_NNS ._.
        Author_NN 6_CD (_( CMV_NNP )_) originally_RB conceived_VBD of_IN the_DT study_NN ,_,
        participated_VBD in_IN its_PRP$ design_NN and_CC coordination_NN and_CC edited_JJ the_DT
        manuscript_NN ._.
        All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
